Europe to Decide Tomorrow on Pfizer Vaccine Approval for Ages 12-15

On the 11th, 12-year-old Maddie Yoo received the Pfizer COVID-19 vaccine in Decatur, Georgia, USA. The U.S. Food and Drug Administration (FDA) approved the emergency use of the Pfizer COVID-19 vaccine for adolescents aged 12 to 15 on the 10th.
[Image source=Reuters Yonhap News]

[Asia Economy Reporter Lee Chun-hee] The European Medicines Agency (EMA) is expected to announce on the 28th (local time) whether to approve the COVID-19 vaccine jointly developed by the US company Pfizer and the German company BioNTech for use in individuals aged 12 to 15.

According to foreign media on the 27th (local time), the Committee for Medicinal Products for Human Use (CHMP) under the EMA will hold an extraordinary meeting on the 28th to reach a conclusion on expanding the use of the Pfizer vaccine to those aged 12 to 15 and will announce the results. Currently, the EMA has approved the use of the Pfizer vaccine for individuals aged 16 and older. The Korea Ministry of Food and Drug Safety has also decided to approve the Pfizer vaccine for those aged 16 and above.

However, earlier on the 10th, the US Food and Drug Administration (FDA) granted emergency use authorization for the Pfizer vaccine to be administered to adolescents aged 12 to 15.

This content was produced with the assistance of AI translation services.